Results
8548
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,548 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AGP | €6.59 | -1.2% | -12.1% | €114.1m | €12.85 | PE16.9x | E22.1% | n/a | Capital Goods | ||
WAYS | SEK 16.16 | -1.5% | -39.4% | SEK 130.4m | SEK 36.50 | PS1.1x | E113.3% | 0% | Tech | ||
CADLR | NOK 62.20 | -5.5% | 32.6% | NOK 21.8b | NOK 82.90 | PE203.6x | E70.9% | n/a | Capital Goods | ||
INIT | SEK 7.25 | -2.0% | -20.2% | SEK 407.0m | SEK 22.50 | PB16.8x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
MVW | NOK 9.10 | 0.6% | 1.1% | NOK 297.7m | NOK 11.70 | PS15.6x | E71.7% | n/a | Materials | ||
GUINNESS | ₦65.00 | -7.5% | 4.8% | ₦142.4b | ₦70.11 | PS0.4x | E121.3% | 0% | Food, Beverage & Tobacco | ||
ICOP | €8.30 | -3.5% | n/a | €229.4m | €9.80 | PE45.4x | E49.2% | n/a | Capital Goods | ||
ELABS | NOK 11.22 | 0.7% | -30.6% | NOK 1.2b | NOK 22.00 | PS12.6x | E111.4% | n/a | Software | ||
AFISH | NOK 70.50 | -3.4% | 17.5% | NOK 2.2b | NOK 81.00 | PE68.5x | E94.4% | n/a | Food, Beverage & Tobacco | ||
NEWBRY | SEK 3.44 | -2.8% | -7.0% | SEK 83.4m | SEK 8.00 | PS2.3x | E130.0% | n/a | Pharmaceuticals & Biotech | ||
RHM | €650.00 | 5.6% | 105.8% | €28.2b | €721.93 | PE41.2x | E29.9% | 0.9% | Capital Goods | ||
TVTX | US$18.09 | -4.1% | 89.8% | US$1.6b | US$27.40 | PS7.7x | E61.9% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$73.80 | 1.9% | 290.5% | US$12.3b | US$75.46 | PS50.3x | E66.3% | n/a | Semiconductors | ||
ARES | US$175.04 | -3.4% | 48.2% | US$54.8b | US$189.31 | PE81.7x | E38.5% | 2.1% | Diversified Financials | ||
ALNY | US$237.98 | 1.6% | 23.1% | US$30.7b | US$298.97 | PS14.7x | E56.4% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$8.11 | -5.6% | 37.0% | US$432.9m | US$20.63 | PS17.7x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
EH | US$14.48 | -6.1% | -0.1% | US$916.4m | US$24.29 | PS19.3x | E79.6% | n/a | Capital Goods | ||
2549 | HK$4.94 | -0.6% | n/a | HK$2.7b | HK$9.25 | PE9.6x | E23.5% | n/a | Consumer Durables | ||
PHM | €77.20 | -6.8% | 93.0% | €1.3b | €83.20 | PE2160.4x | E56.2% | 0.8% | Pharmaceuticals & Biotech | ||
RCEL | US$9.14 | -31.0% | -37.3% | US$241.5m | US$17.34 | PS4x | E51.8% | n/a | Pharmaceuticals & Biotech | ||
ANUP | ₹3,092.70 | -12.0% | 116.5% | ₹61.9b | ₹4,000.00 | PE51.7x | E20.6% | 0.2% | Capital Goods | ||
BTR | AU$0.02 | 0% | 33.3% | AU$142.7m | AU$0.052 | PS135.3x | E84.5% | n/a | Materials | ||
CDR | zł192.15 | -2.0% | 77.9% | zł19.2b | zł145.78 | PE43.7x | E27.0% | 0.5% | Media | ||
ALKT | US$34.15 | -9.0% | 37.3% | US$3.4b | US$44.60 | PS10.9x | E102.7% | n/a | Software |